Objective. The aim was to determine whether the time trade-off (TTO) and standard gamble utilities can detect treatment-related improvement in overall quality of life in patients with active RA.
Introduction
Treatment efficacy is most often judged by improvement in symptoms, functioning or physiological or anatomical abnormalities [1] . Alternatively, efficacy can be judged by the value associated with being in a better state of health [2, 3] . Value of health is a concept that integrates all aspects of illness in a single measure. In this more holistic assessment, a treatment that improves pain but causes confusion, for example, may not be judged favourably. Utilities are measures of the value ascribed to states of health, most often scaled from 0, representing death, to 1, representing perfect health [2, 4] . Given that utilities are generic, they can be used in comparisons across diseases and across investments among different treatments in costutility analyses [4, 5] . As they integrate symptom improvements and side effects, utilities are attractive as summary measures in clinical trials.
Two reference measures of utilities are the time tradeoff (TTO) and standard gamble [2, 4] . The TTO measures value by asking subjects if they are willing to trade increased quality of life for a shorter length of life. The standard gamble measures value by asking how much risk a person is willing to accept in exchange for better health. People who value their current health highly will be less likely to trade away years or gamble for a chance at better health, and therefore have higher utility.
Both methods are typically administered using interviews. Use of the TTO and standard gamble has been limited by the need for trained interviewers, often long time requirements and potential susceptibility of responses to interviewer guidance. Consequently, indirect methods that estimate utilities from health status questionnaires, such as the EuroQoL-5 Dimensions (EuroQoL-5D) and Short Form-6D (SF-6D), have become popular [6] . However, indirect utility measures have theoretical and practical limitations that include having values assigned for a limited number of health states [4, 7] .
Most studies of utilities in RA have used indirect measures [8] . Cross-sectional studies of the TTO or standard gamble reported modest reductions in utilities relative to perfect health among patients with RA, and low correlations with measures of RA activity [915] . However, these findings do not provide information on how well utilities capture changes in quality of life with treatment. Among seven clinical trials that included either the TTO or standard gamble, small but significant increases in utilities were observed in four trials [1620] . In two trials, utilities were not able to distinguish between treatment groups [21, 22] . Responsiveness of the standard gamble was lower than that of RA activity measures in two studies [18, 20] . The conclusions from these studies were that utilities were generally poor measures of treatment response in RA. The trials included tests of auranofin, erythropoietin and day-hospital treatment, which may not have been sufficiently potent interventions to observe an effect on utilities.
Given that utilities are not specifically measures of RA activity, but global quality-of-life measures influenced by co-morbidities, mood and patients' risk tolerances, and non-health concerns, we considered that treatments targeting RA activity might be expected to have only a limited impact on utilities. Consequently, any demonstrable effect of treatment on utilities would establish these as applicable measures of overall quality of life in clinical trials. We tested whether the TTO and standard gamble could detect treatment-related improvement in a prospective observational study of patients with active RA, with the primary null hypothesis that the TTO and standard gamble would not change with treatment. We compared their performance not only with other RA activity measures but also with mental health measures, because mental health is likewise not the primary target of antirheumatic treatment but may improve with improvements in arthritis activity. We also compared their validity with that of the SF-6D.
Methods
Subjects and study design Subjects were participants in a prospective longitudinal study to determine clinically important changes in RA activity measures [23] . We enrolled adults who had active RA and had treatment escalation at the baseline visit. Treatment escalation could include the initiation of prednisone, initiation of a new disease-modifying medication or biologic, or an increase in the dose of prednisone or disease-modifying medication. The study was approved by the National Institute of Diabetes, Digestive and Kidney Diseases/National Institute of Arthritis and Musculoskeletal and Skin Diseases institutional review board, and all subjects provided written informed consent.
The study consisted of a baseline visit, and a follow-up visit either 1 month (for prednisone-treated subjects) or 4 months later (for all others). At each visit, we performed joint counts, measured acute phase reactants and asked subjects to complete health status questionnaires. At the follow-up visit, we asked subjects to report whether their arthritis had improved, worsened or was unchanged since baseline [24] .
Of 262 subjects enrolled, 206 subjects (79%) participated in an optional sub-study of utilities that included a computer-administered assessment of the TTO and standard gamble. The main reasons for non-participation in the sub-study were lack of time and primary language other than English. Of these, 192 subjects (93%) completed the utility measures at both visits and were included.
Utility measurements
Utilities were measured using U-titre, a computer program for preference assessment [2529] . The program first leads subjects through brief training exercises on performing the TTO and standard gamble before assessing utilities for their current health. The program detects inconsistent responses and prompts subjects to reconsider when these occur. Computer-administered assessments have been shown to provide reliable and valid utility measurements, and have an advantage over interviews in presenting the response options objectively and consistently [15, 2630] . To our knowledge, U-titre has not previously been used in studies of RA.
The TTO presents subjects with a series of binary choices to trade shorter lengths of life in ideal health for a longer life in their present state of health [25, 27] . Options for the number of years in ideal health were determined using the bisection method, and ping-ponged until the subject was indifferent between the options. Subjects who did not trade any years of life for ideal health had a TTO utility of 1.0.
The standard gamble asks subjects to choose between remaining in their present state of health or taking a magic pill that would, with some varying probability, result either in ideal health for the rest of their life or immediate painless death [25, 30] . Options for the probability of cure or death varied between 100 and 0% using the bisection method, and ping-ponged until the subject was indifferent between the options. Subjects unwilling to accept any risk of death in exchange for ideal health had a standard gamble utility of 1.0.
For comparison, we computed the SF-6D, a preference measure based on items of the Short Form-36 [31] . The SF-6D is based on weights derived from standard gamble utilities [range 0.30 1.0 (full health)].
RA activity and health status measures
The patient global assessment and pain scores were measured using 10 cm visual analog scales, with ranges of 0100 (higher scores indicated worse health) [32] . We used the HAQ Disability Index as the measure of functional ability (possible range 03, with higher scores indicating more limitations) [33] . From joint counts and the serum CRP concentration, we computed the DAS28 [34] .
We computed the Physical Component Summary and the Mental Component Summary of the Short Form-36 [35] . Both scores were normalized to a mean of 50, and higher scores indicated better health. We included the Center for Epidemiologic Studies-Depression (CES-D) scale, a 20-item scale that asks about the frequency of depressive symptoms (possible range 060, with higher scores indicating more frequent symptoms) [36] . We included the latter two scales as mental health comparators.
Statistical analysis
To describe the relationship between the TTO and standard gamble and the RA activity measures, we computed Spearman correlations between measures at baseline, and between changes in measures during the study. We considered correlations with absolute values between 0.1 and 0.29 as small, 0.30.49 as moderate and 50.5 as large [37] . As ceiling effects may diminish the ability to demonstrate change, we repeated the analyses excluding subjects with utilities 50.99 at the baseline visit.
Our main goal was to investigate the longitudinal construct validity of the TTO and standard gamble. We examined three comparisons hypothesized to be associated with variations in subjects' utilities. As our primary comparison, we tested whether the TTO and standard gamble improved in association with treatment between the baseline and follow-up visit, using the Wilcoxon signed rank test. Secondly, we tested whether changes in the TTO and standard gamble were related to patient judgement of improvement or worsening in their global arthritis status at the follow-up visit, using tests for trend in an analysis of variance model. We hypothesized that utilities would increase in those who reported improvement and decrease in those who reported worsening. Likewise, we tested whether changes in the TTO and standard gamble varied with EULAR response criteria (good, moderate and no response), using tests for trend in an analysis of variance model [38] . We also computed these associations for RA activity measures.
The TTO and standard gamble assess the value that subjects place on their present health, rather than health itself, and are influenced by risk aversion and other potential biases [2, 39, 40] . As these attributes increase the variance of these measures, smaller effect sizes were hypothesized for the TTO and standard gamble than for RA activity and health status measures, which assess health directly and are targeted by treatment. We hypothesized that the effect size of differences in utilities across categories of patient-reported improvement or EULAR responses, measured by Cohen's ƒ, would be detectable but small (0.10.24), whereas the RA activity measures would have large effect sizes (50.4) [41] .
To measure responsiveness, we used the standardized response mean, which was computed as the mean change divided by the standard deviation of the change in each measure [42] . We considered standardized response means with absolute values of 0.200.49 as small, 0.500.79 as moderate and 50.80 as large [41] . We computed 95% CIs for effect sizes and standardized response means using 2000 bootstrapped samples. We used SAS version 9.3 (SAS Institute, Cary, NC, USA) for analysis.
Results

Subjects
Subjects were mostly middle-aged women for whom RA was the main health problem (Table 1) . Compared with those included in the analysis, those who did not participate in the sub-study were on average 5 years younger (P < 0.0001), were more often women (88%; P = 0.03) and had slightly higher mean (S.D.) DAS28 [5.79 (1.1)] at baseline (P = 0.12).
Baseline associations
At baseline, subjects had active RA, with a mean pain score of 58.3 and mean DAS28 of 5.46 (Table 2 ). The mean TTO utility was 0.68 (median 0.82). Twelve per cent of subjects were at the floor (TTO = 0) and 27.6% were at the ceiling (TTO 50.99; supplementary Fig. S1 , available at Rheumatology Online). The mean standard gamble utility was 0.80 (median 0.93); 4% were at the floor and 34.3% were at the ceiling (supplementary Fig.  S1 , available at Rheumatology Online). Thirty-six subjects (19%) had utilities at the ceiling on both measures. Despite high valuation of their health, subjects at the ceiling were quite symptomatic (supplementary Table S1 , available at Rheumatology Online). The mean SF-6D was 0.60 (median 0.60), and no subjects were at the floor or ceiling. Seventy-two per cent reported that the computer assessment of utilities was easy, and 5% reported being very confused by it (supplementary methods and supplementary Table S2 , available at Rheumatology Online). At baseline, there was a moderate correlation between the TTO and standard gamble (r = 0.47), but substantially lower correlations with RA activity measures (supplementary Table S3 , available at Rheumatology Online). Correlations with the standard gamble were higher when subjects at the ceiling were excluded (supplementary Table S4 , available at Rheumatology Online). Correlations of the TTO and standard gamble with the CES-D and Mental Component Summary were comparable to those with other RA activity measures, suggesting that psychological factors were related in a similar manner to how subjects valued their present health (supplementary Table S3 , available at Rheumatology Online). The SF-6D and RA activity measures were moderately to highly correlated.
Longitudinal changes in measures
Both the TTO and standard gamble utilities improved significantly in association with treatment (Table 2) . Most subjects with a baseline TTO or standard gamble of 0.8 or less had an increase in utility during the study (supplementary (Table 2) . Standardized response means of the other RA activity measures were moderate to high. The treatment-related improvement in the TTO and standard gamble was somewhat larger among subjects treated with prednisone than those treated with disease-modifying medications or dose escalation, which paralleled the improvements in the RA activity and health status measures in these groups (supplementary Table S5 , available at Rheumatology Online).
At the follow-up visit, 117 subjects reported improvement in their overall arthritis status, 52 subjects judged themselves unchanged and 23 subjects reported worsening. Subjects who reported improvement had larger increases in both the TTO and standard gamble than those who were unchanged or worsened, but differences were not significant (Table 3 ). In contrast, the SF-6D and all clinical measures differed among these groups. Notably, subjects who reported being unchanged or worsened had sizable increases in their TTO utilities, which were not seen with the standard gamble. Effect sizes of the TTO and standard gamble were small but detectable, and smaller than those of the CES-D and Mental Component Summary. Excluding subjects at the ceiling did not change the effect sizes of the TTO (0.15; 95% CI: 0.03, 0.34) or standard gamble (0.14; 95% CI: 0.05, 0.32).
Thirty-four subjects had a EULAR good response and 73 subjects had a EULAR moderate response. Although there was no association between the TTO and EULAR response, a graded association was present for the standard gamble and for all clinical measures except CRP (Table 4) . Effect sizes of the TTO and standard gamble were low, but comparable to the CES-D and Mental Component Summary. Excluding subjects at the ceiling resulted in only minor increases in the effect sizes of the 
Changes in quality-adjusted life years
We used the change in utilities to estimate the change in quality-adjusted life years experienced by the cohort during the study, assuming their utilities would have remained unchanged without treatment escalation. Based on changes in the TTO, the cohort gained 5.8 quality-adjusted life years. Based on changes in the standard gamble and SF-6D, the gains were 2.4 and 2.2 years, respectively.
Discussion
Both the TTO and standard gamble utilities improved significantly in our cohort of patients with active RA in association with standard anti-rheumatic treatment. Utilities and RA activity measures both improved more in subjects treated with prednisone, supporting the construct validity of the TTO and standard gamble. Changes in the TTO and standard gamble were correlated with changes in pain scores, HAQ and DAS28, but these correlations were small. Changes in the utilities were not significantly associated with patient-reported improvement in arthritis, but the standard gamble was associated with EULAR responses. Although the utility measures have a more general focus on quality of life, the scores improved in patients after treatment for RA.
Few studies have examined the longitudinal concurrent validity of direct utility measures in RA. Peeters and colleagues [17] reported a correlation of À0.31 between changes in the standard gamble and DAS in a small trial, while Ariza-Ariza and colleagues [43] reported an association of similar magnitude between changes in the TTO and DAS28. We found slightly smaller correlations, which may have been because most subjects improved. Had more patients worsened, the expanded range of changes in RA activity would have likely resulted in higher correlations, because correlations are influenced by extreme values. In cross-sectional studies, correlations between utilities and RA activity measures typically ranged from 0.1 to 0.3 (absolute values), which were similar to our results [915] . Correlations of the SF-6D were substantially larger.
Although there were graded changes in the TTO and standard gamble with categories of patient-reported improvement, these associations were small. Paradoxically, the TTO increased on average among subjects who judged their arthritis to have worsened during the study, which suggests issues with its specificity. The TTO also had non-hierarchical associations with EULAR responses, and increased in subjects who did not meet criteria for a EULAR response. These non-specific increases accounted for the larger gain in quality-adjusted life years with the TTO than with the standard gamble and SF-6D. By these standards, the standard gamble appears to have better construct validity than the TTO. The effect sizes of the standard gamble were small, but non-zero.
Compared with RA activity measures (except CRP), the TTO and standard gamble would appear to have low applicability in RA trials. However, this interpretation does not recognize that utilities are conceptually distinct from disease activity measures, in that they primarily reflect preferences. Although utilities would be expected to be related to health to some degree, the notion that patients' utilities should be tightly linked to measures of health is likely to be mistaken [44] . Studies have found that utilities of patients with severe angina were often higher than those with mild angina, and that utilities were commonly high among patients with HIV and hepatitis C infections, and only weakly associated with symptoms [26, 45] . Likewise, in another study, most patients hospitalized with advanced heart failure had high TTO utilities, and utilities correlated only modestly with symptoms and functional ability [46] . The development of indirect preference measures has probably reinforced the notion that utilities should be determined primarily by health status by making explicit connections between the two. Our results support the conceptual distinction between utilities and health status. Utilities may be seen as measures that are one step further removed from RA activity than mental health measures, which had effect sizes that were intermediate between those of the utilities and the core RA measures. Like utilities, mental health is indirectly impacted by RA, but unlike utilities, mental health measures do not include an accounting of values and preferences. The degree of association we found between utilities, mental health measures and physical health measures and the standards used for comparison parallels their conceptual relatedness as measures of RA activity.
Responsiveness of the TTO and standard gamble was similar to the mental health measures, again suggesting that these sets of measures have a different relationship with treatment-induced changes in health than the core RA measures. Improvements in utilities, like improvements in mental health, were probably secondary to improvements in physical health that were the target of treatment. Our results indicate that despite the variety of influences on utilities, anti-rheumatic treatment provided a strong enough stimulus to improve utilities significantly, even when a sizeable proportion of patients were at the ceiling at baseline. This is an important consideration in the use of utilities in clinical trials. Most subjects found the assessment easy, and computer administration made testing more feasible because trained interviewers were not needed.
The SF-6D had stronger associations with the standards than did the utility measures. Although the SF-6D was also more responsive, the gain in utilities and quality-adjusted life years based on the SF-6D was very similar to that of the standard gamble. Increases in the SF-6D are largely related to improvements among patients in poor health, because of the weighting of its component items [31] . Given that improvements in the standard gamble are also concentrated among patients in poor health, the increase in the standard gamble with treatment was comparable to that of the SF-6D, despite its ceiling effect. Preference weights of the SF-6D were based on the standard gamble, which may also contribute to the close agreement of quality-adjusted life years based on these measures. Our results indicate that the better construct validity and responsiveness of indirect utility measures may not necessarily translate into better estimates of quality-of-life gains compared with the standard gamble.
Our study is limited in not having an independent measure of overall quality of life with which utilities could be compared. Instead, we used changes in RA-related health. This limitation is shared with most studies of utilities [44] . We also did not examine why some patients reported very high utilities despite active RA or why utilities decreased in some patients despite treatment. These questions may be best investigated in qualitative studies. We did not compare interviewer-administered and computer-administered methods of assessment, although studies suggest these provide similar results [15] . We also did not study the EuroQol-5D or other indirect measures. The TTO and standard gamble in the present study are susceptible to a number of cognitive biases, including misspecification bias and anchoring bias, as they are in other studies [47] .
The direct utility measures used in this study are generic measures of quality of life, and not health status. Despite this broad scope, changes in the TTO and standard gamble were associated with improvements in arthritis status with anti-rheumatic treatment in a cohort of patients with active RA. These results support the 
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